Sign-up for more details including this 2-page comparison PDF.
You might also be interested in our 20% discount on new HRAs.
Copyright © 2022 Medicom Health LLC • All rights reserved.
NEW MEDICOM HEALTH HRA
Check out this client- requested alternative to our standard Breast Cancer Risk Assessment
We think many health systems will prefer this more modern approach, but the older one will remain available.
Complete the form for in-depth information.
This new Breast Cancer Screening assessment uses a lighter-weight consumer-oriented questionnaire on genetic factors with limited family history questions.
The primary result is a recommendation to seek genetic or imaging-based breast cancer screening (if needed) as based on a combination the newer FHS-7 and USPSTF algorithms.
These action-oriented results require less interpretation than percentages or categories. The 5-page report includes a lot of other tailored messaging including new content for people with LCIS, DCIS, known genetic markers and previous breast cancer.
A Quick Comparison of Our TwoBreast Cancer Assessments
NEW FOR 2022
GAIL MODEL
New Breast Cancer Assessment
Medicom Health converts web visits to care visits! Over 1,300 hospitals trust our service line-specific health risk assessments (HRAs) to engage millions of patients each year. Many customization, automation & mar-tech integration options are available and we add new features regularly. All development is by our long-standing, in-house team. Plus, we are HITRUST certified!
Contact us today for a quick demo!
Eruptr helped pioneer search marketing for healthcare and continues to lead the industry today with a full suite of digital marketing services delivered to 70+ influential health systems representing over 200 hospitals and clinics.
Visit their website for more information.
Eruptr and Medicom Health are now Unlock Health companies.